See also this year's filing and all EDGAR filings for this company.
PDF Report 0001560241_2018_G1_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001560241, G1 Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 104,661,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 510,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 11,704,000 |
| 5 | LiabilitiesNoncurrent | 79,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,087,000 |
| 9 | ResearchAndDevelopmentExpense | 53,881,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 847,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 105,171,000 |
| 1 | Liabilities | 11,783,000 |
| 2 | Expenses | 60,968,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 93,388,000 |
| 5 | NetIncome | -60,121,000 |
| 6 | ComprehensiveNetIncome | -60,121,000 |
| 7 | BaseVar | 89,384,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.45 |
| 9 | EconomicCapitalRatio | 3.32 |